These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37131608)

  • 1. Antivirals against monkeypox infections.
    Chiem K; Nogales A; Lorenzo M; Vasquez DM; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Mart Nez-Sobrido L
    bioRxiv; 2023 Apr; ():. PubMed ID: 37131608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of
    Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
    Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
    Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K
    Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates.
    Prévost J; Sloan A; Deschambault Y; Tailor N; Tierney K; Azaransky K; Kammanadiminti S; Barker D; Kodihalli S; Safronetz D
    Antiviral Res; 2024 Nov; 231():105995. PubMed ID: 39243894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying potential monkeypox virus inhibitors: an
    Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
    Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?
    Tiecco G; Degli Antoni M; Storti S; Tomasoni LR; Castelli F; Quiros-Roldan E
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monkeypox virus: Future role in Human population.
    Farasani A
    J Infect Public Health; 2022 Nov; 15(11):1270-1275. PubMed ID: 36272392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses.
    Wang J; Shahed-Ai-Mahmud M; Chen A; Li K; Tan H; Joyce R
    J Med Chem; 2023 Apr; 66(7):4468-4490. PubMed ID: 36961984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus.
    Rohaim MA; Naggar RFE; Atasoy MO; Munir M
    Adv Exp Med Biol; 2024; 1451():111-124. PubMed ID: 38801574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monkeypox virus: a re-emergent threat to humans.
    Gong Q; Wang C; Chuai X; Chiu S
    Virol Sin; 2022 Aug; 37(4):477-482. PubMed ID: 35820590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monkeypox virus: The changing facets of a zoonotic pathogen.
    Forni D; Cagliani R; Molteni C; Clerici M; Sironi M
    Infect Genet Evol; 2022 Nov; 105():105372. PubMed ID: 36202208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic targets for Mpox: the evidence to date.
    Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
    Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
    Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
    Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2022 Monkeypox outbreak: How the medicinal chemistry could help us?
    Silva-Júnior EFD
    Bioorg Med Chem; 2022 Nov; 73():117036. PubMed ID: 36183614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus.
    Li M; Ren Z; Wang Y; Jiang Y; Yang M; Li D; Chen J; Liang Z; Lin Y; Zeng Z; Xu R; Wang Y; Zhu L; Xiao W; Wu Q; Zhang B; Wan C; Yang Y; Wu B; Peng J; Zhao W; Shen C
    Emerg Microbes Infect; 2023 Dec; 12(2):2223669. PubMed ID: 37288876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment.
    Sun Y; Nie W; Tian D; Ye Q
    J Clin Virol; 2024 Apr; 171():105662. PubMed ID: 38432097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.